- €248.63m
- €342.96m
- €1.21bn
- 75
- 96
- 35
- 81
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,162 | 1,131 | 1,044 | 1,148 | 1,209 |
Cost of Revenue | |||||
Gross Profit | 348 | 355 | 333 | 374 | 415 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,159 | 1,096 | 1,001 | 1,088 | 1,125 |
Operating Profit | 2.67 | 35.1 | 43.4 | 60.8 | 84.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.1 | 22.7 | 34 | 47.5 | 66 |
Provision for Income Taxes | |||||
Net Income After Taxes | -15.2 | 14.5 | 45.6 | 45.8 | 60 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -15.3 | 13.4 | 44.9 | 45.6 | 59.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -15.3 | 13.4 | 44.9 | 45.6 | 59.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.198 | 0.708 | 1.07 | 1.06 | 1.38 |
Dividends per Share |